[go: up one dir, main page]

CU23102A1 - Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos - Google Patents

Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Info

Publication number
CU23102A1
CU23102A1 CU20020235A CU20020235A CU23102A1 CU 23102 A1 CU23102 A1 CU 23102A1 CU 20020235 A CU20020235 A CU 20020235A CU 20020235 A CU20020235 A CU 20020235A CU 23102 A1 CU23102 A1 CU 23102A1
Authority
CU
Cuba
Prior art keywords
proteins
production
mammary gland
recombinant proteins
transgenic mammals
Prior art date
Application number
CU20020235A
Other languages
English (en)
Inventor
Ramos Oliberto Sanchez
Alonso Jorge Roberto Toledo
Molto Maria Pilar Rodriguez
Reboredo Fidel Ovidio Castro
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Priority to CU20020235A priority Critical patent/CU23102A1/es
Priority to ARP030103775A priority patent/AR041644A1/es
Priority to RU2005115495/13A priority patent/RU2345088C2/ru
Priority to BR0315555-2A priority patent/BR0315555A/pt
Priority to CNA2003801034448A priority patent/CN1744814A/zh
Priority to AU2003273726A priority patent/AU2003273726B8/en
Priority to JP2004543918A priority patent/JP2006503560A/ja
Priority to MXPA05004295A priority patent/MXPA05004295A/es
Priority to EP03757653A priority patent/EP1557084A2/en
Priority to KR1020057006830A priority patent/KR20050083791A/ko
Priority to PCT/CU2003/000011 priority patent/WO2004034780A2/es
Priority to CA002502902A priority patent/CA2502902A1/en
Priority to ZA200503166A priority patent/ZA200503166B/en
Publication of CU23102A1 publication Critical patent/CU23102A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/861Adenoviral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/102Caprine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Método que permite la producción de proteínas de interés bio-farmacéutico a partir de la glándula mamaria de animales no transgénicos. Los genes que codifican para dichas proteínas son transferidos a las células epiteliales mamarias empleando vectores adenovirales. Tales vectores pueden estar basados en adenovirus con replicación defectiva como el ?E1?E3. o en adenovirus dependientes de ayudantes a los cuales se les han eliminado todas o casi todas la secuencias adenovirales codificantes. Mediante este método es posible la producción altos niveles de proteínas recombinantes en la leche permitiendo de esta forma la producción a gran escala de proteínas de interés biofarmacéutico en su forma biológicamente activa.
CU20020235A 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos CU23102A1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
ARP030103775A AR041644A1 (es) 2002-10-21 2003-10-16 Metodo para la produccion de proteinas recombinantes en la glandula mamaria de mamiferos no transgenicos
RU2005115495/13A RU2345088C2 (ru) 2002-10-21 2003-10-20 Способ получения рекомбинантных белков в молочной железе нетрансгенных млекопитающих
BR0315555-2A BR0315555A (pt) 2002-10-21 2003-10-20 Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais
CNA2003801034448A CN1744814A (zh) 2002-10-21 2003-10-20 从非转基因哺乳动物乳腺生产重组蛋白质的方法
AU2003273726A AU2003273726B8 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
JP2004543918A JP2006503560A (ja) 2002-10-21 2003-10-20 非形質転換哺乳動物の乳腺における組換えタンパク質の製造法
MXPA05004295A MXPA05004295A (es) 2002-10-21 2003-10-20 Metodo para la produccion de proteinas recombinantes en la glandula mamaria de mamiferos no transgenicos.
EP03757653A EP1557084A2 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
KR1020057006830A KR20050083791A (ko) 2002-10-21 2003-10-20 비-유전자도입 포유동물의 유선에서 재조합 단백질의생산방법
PCT/CU2003/000011 WO2004034780A2 (es) 2002-10-21 2003-10-20 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
CA002502902A CA2502902A1 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
ZA200503166A ZA200503166B (en) 2002-10-21 2005-04-19 Method of producing recombinant proteins in the mammary gland on non-transgenic mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Publications (1)

Publication Number Publication Date
CU23102A1 true CU23102A1 (es) 2005-12-20

Family

ID=40134844

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Country Status (13)

Country Link
EP (1) EP1557084A2 (es)
JP (1) JP2006503560A (es)
KR (1) KR20050083791A (es)
CN (1) CN1744814A (es)
AR (1) AR041644A1 (es)
AU (1) AU2003273726B8 (es)
BR (1) BR0315555A (es)
CA (1) CA2502902A1 (es)
CU (1) CU23102A1 (es)
MX (1) MXPA05004295A (es)
RU (1) RU2345088C2 (es)
WO (1) WO2004034780A2 (es)
ZA (1) ZA200503166B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23544A1 (es) * 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
CU23576A1 (es) * 2006-02-28 2010-09-30 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la influenza aviar
CN1869217B (zh) * 2006-05-22 2013-08-07 李青旺 以腺病毒为载体乳腺表达生产转基因蛋白药物的方法
AU2009266603B2 (en) 2008-06-30 2013-01-24 Cho-A Pharm Co., Ltd. Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
KR20140132706A (ko) * 2011-12-19 2014-11-18 엘에프비 유에스에이, 인크. 염증성 장애의 치료를 위한 재조합 인간 알파-1-안티트립신
CL2014002410A1 (es) * 2014-09-12 2014-11-14 Univ Concepcion Método para la producción de proteínas recombinantes en glándula mamaria de mamíferos mediante la transformación del epítelio glandular mamario con vectores adenoasociados.
WO2018085967A1 (en) * 2016-11-08 2018-05-17 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Genetically humanized mammals expressing human serum albumin and uses thereof
ES2980492T3 (es) 2019-07-25 2024-10-01 Medichem Sa Procedimiento para la síntesis de N-alquil-4-piridinaminas
WO2025252759A1 (en) 2024-06-03 2025-12-11 Bio-Sourcing Transient expression by lipid nanoparticle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780009A (en) * 1995-01-20 1998-07-14 Nexia Biotechnologies, Inc. Direct gene transfer into the ruminant mammary gland
WO1997017090A1 (en) * 1995-11-07 1997-05-15 Baylor College Of Medicine Adenovirus-mediated production of bioactive proteins by mammalian cells and animals
JP2002514904A (ja) * 1996-06-20 2002-05-21 メルク エンド カンパニー インコーポレーテッド 肥満に対する遺伝子治療
NZ506478A (en) * 1998-02-24 2003-07-25 Ca Minister Agriculture & Food Trans-somatics with gene transfer into mammary epithelial cells
AU2002228730A1 (en) * 2000-10-27 2002-05-06 Beth Israel Deaconess Medical Center, Inc. Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis

Also Published As

Publication number Publication date
CN1744814A (zh) 2006-03-08
EP1557084A2 (en) 2005-07-27
AU2003273726A1 (en) 2004-05-04
WO2004034780A3 (es) 2004-05-27
WO2004034780A2 (es) 2004-04-29
RU2005115495A (ru) 2005-11-20
RU2345088C2 (ru) 2009-01-27
BR0315555A (pt) 2005-08-23
MXPA05004295A (es) 2005-08-03
AR041644A1 (es) 2005-05-26
AU2003273726B2 (en) 2009-07-09
AU2003273726B8 (en) 2009-09-03
CA2502902A1 (en) 2004-04-29
KR20050083791A (ko) 2005-08-26
JP2006503560A (ja) 2006-02-02
ZA200503166B (en) 2006-10-25

Similar Documents

Publication Publication Date Title
Kiyomitsu et al. The nuclear mitotic apparatus (NuMA) protein: A key player for nuclear formation, spindle assembly, and spindle positioning
Santos et al. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors
Wassarman et al. Zona pellucida genes and proteins: essential players in mammalian oogenesis and fertility
CU23102A1 (es) Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
Aranjuez et al. Dynamic myosin activation promotes collective morphology and migration by locally balancing oppositional forces from surrounding tissue
PE20221770A1 (es) Composiciones de proteina anti-vegf y metodos para producir la misma
DE602006011574D1 (de) Leitsequenzen zur anleitung von polypeptidsekretion und verfahren zur herstellung
AR080229A1 (es) Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23)
ES2531135T3 (es) Fitasas, ácidos nucleicos que las codifican y métodos para su producción y uso
CU24483B1 (es) Método para incrementar los niveles de secreción de la interleucina-2
MX384304B (es) Polipéptidos y polinucleótidos aislados y métodos para su uso, para aumentar el rendimiento, la biomasa, el índice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estrés abiótico de las plantas y la eficiencia en el uso de nitrógeno.
GT201000148A (es) Anticuerpos antimesotelina y usos de los mismos
PE20110358A1 (es) Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias
Wilson et al. Evolution of the multi‐tubulin hypothesis
CO6300796A2 (es) Proceso para la produccion de proteina exogena en la leche de mamifero transgenico
ES2553329T3 (es) Huésped recombinante para la producción de L-asparaginasa II
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
Sahoo et al. Characterization of calumenin in mouse heart.
Szikora et al. The mechanisms of thin filament assembly and length regulation in muscles
AR026571A1 (es) Genes del musgo de la physcomitrella patens que codifican proteinas que participan en la sintesis de los acidos grasos poliinsaturados y lipidos
Heffernan et al. The trials and tubule-ations of Rab6 involvement in Golgi-to-ER retrograde transport
AR046953A1 (es) Variantes de genes que codifican para proteinas de la via de metabolismo de productos quimicos puros
Yasumasu et al. Mechanism of egg envelope digestion by hatching enzymes, HCE and LCE in medaka, Oryzias latipes
ES2489715T3 (es) Procedimiento para la produccíón de colágeno humano de tipo II
JP2011505850A5 (es)